Patents by Inventor Yves-Louis JANIN

Yves-Louis JANIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
    Patent number: 11938199
    Abstract: The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: March 26, 2024
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Yves-Louis Janin, Eloi Paul Coutant, Vincent Hervin, Glwadys Gagnot, Yves Jacob, Sophie Goyard, Thierry Rose
  • METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20230181539
    Abstract: Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The emergence of a new beta-coronavirus SARS-CoV-2 has led to a major health-related crisis associated with a significant mortality in intensive care units, due to the pulmonary complications of COVID-19. The inventors showed that BAY-2402234 is suitable for inhibiting replication of coronavirus and thus would be suitable for the treatment of infections mediated by said type of virus.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 15, 2023
    Inventors: Pierre-Olivier VIDALAIN, Antoine NOUGAIREDE, Franck TOURET, Patrice ANDRE, Vincent LOTTEAU, Xavier Nicolas LAMBALLERIE, Yves Louis JANIN
  • IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS
    Publication number: 20200129644
    Abstract: The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.
    Type: Application
    Filed: April 30, 2018
    Publication date: April 30, 2020
    Inventors: Yves-Louis JANIN, Eloi Paul COUTANT, Vincent HERVIN, Glwadys GAGNOT, Yves JACOB, Sophie GOYARD, Thierry ROSE